Phase I/II clinical and pharmacokinetic study of ecubectedin in combination with irinotecan in patients with selected advanced solid tumors

被引:0
|
作者
Torralvo, A. Gil [1 ]
Vieito, M. [2 ]
Martinez Perez, J. [1 ]
Pretelli, G. [2 ]
Martinez, V. [3 ]
Boggio, G. F. [4 ]
Fernandez, C. M. [4 ]
Hernandez, A. [4 ]
Cristoveanu, E. [4 ]
Belgrano, A. [4 ]
Kahatt, C. [4 ]
Fudio, S. [4 ]
Nieto, A. [4 ]
Redondo, A. [3 ]
机构
[1] Hosp Univ Virgen Rocio, Oncol, Seville, Spain
[2] VHIO Vall dHebron Inst Oncol, Oncol, Barcelona, Spain
[3] Hosp Univ La Paz, Dept Oncol Med, Madrid, Spain
[4] PharmaMar SA, Clinical, Colmenar Viejo, Spain
关键词
D O I
10.1016/j.annonc.2024.08.708
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
641P
引用
收藏
页码:S508 / S508
页数:1
相关论文
共 50 条
  • [31] A phase I and pharmacokinetic study of exisulind and docetaxel in patients with advanced solid tumors
    Witta, SE
    Gustafson, DL
    Pierson, AS
    Menter, A
    Holden, SN
    Basche, M
    Persky, M
    O'Bryant, CL
    Zeng, C
    Baron, A
    Long, ME
    Gibbs, A
    Kelly, K
    Bunn, PA
    Chan, DC
    Pallansch, P
    Eckhardt, SG
    CLINICAL CANCER RESEARCH, 2004, 10 (21) : 7229 - 7237
  • [32] A phase I and pharmacokinetic study of losoxantrone and paclitaxel in patients with advanced solid tumors
    Diab, SG
    Baker, SD
    Joshi, A
    Burris, HA
    Cobb, PW
    Villalona-Calero, RA
    Eckhardt, SG
    Weiss, GR
    Rodriguez, GI
    Drengler, R
    Kraynak, M
    Hammond, L
    Finizio, M
    Von Hoff, DD
    Rowinsky, EK
    CLINICAL CANCER RESEARCH, 1999, 5 (02) : 299 - 308
  • [33] Phase I study of capecitabine in combination with cisplatin and irinotecan in patients with advanced solid malignancies
    H. Sayar
    Z. Shen
    S. J. Lee
    M. Royce
    I. Rabinowitz
    F. Lee
    H. Smith
    S. Eberhardt
    A. Maestas
    H. Lu
    C. Verschraegen
    Investigational New Drugs, 2009, 27 : 153 - 158
  • [34] Phase I study of capecitabine in combination with cisplatin and irinotecan in patients with advanced solid malignancies
    Sayar, H.
    Shen, Z.
    Lee, S. J.
    Royce, M.
    Rabinowitz, I.
    Lee, F.
    Smith, H.
    Eberhardt, S.
    Maestas, A.
    Lu, H.
    Verschraegen, C.
    INVESTIGATIONAL NEW DRUGS, 2009, 27 (02) : 153 - 158
  • [35] UFT in combination with oxaliplatin:: clinical phase I study in patients with advanced or metastatic solid tumors
    Sastre, Javier
    Aranda, Enrique
    Abad, Albert
    Gallego, Javier
    Luis Manzano, Jose
    Gomez, Auxiliadora
    Carrato, Alfredo
    Lopez, Eva
    Diaz-Rubio, Eduardo
    ANTI-CANCER DRUGS, 2006, 17 (04) : 417 - 421
  • [36] A Phase I Study of a Combination of Liposomal Irinotecan and Veliparib in Solid Tumors
    LaRose, Meredith
    Connolly, Roisin M.
    O'Sullivan, Ciara C.
    Velcheti, Vamsidhar
    Vilimas, Rasa
    Gano, Katherine
    Bates, Susan E.
    Pommier, Yves
    Thomas, Anish
    ONCOLOGIST, 2023, 28 (05): : 460 - +
  • [37] Phase I clinical and pharmacokinetic study of oral S-1 in patients with advanced solid tumors
    van Groeningen, CJ
    Peters, GJ
    Schornagel, JH
    Gall, H
    Noordhuis, P
    de Vries, MJ
    Turner, SL
    Swart, MS
    Pinedo, HM
    Hanauske, AR
    Giaccone, G
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (14) : 2772 - 2779
  • [38] A phase I dose-escalation and pharmacokinetic study of sunitinib in combination with docetaxel in patients with advanced solid tumors
    Robert, F.
    Sandler, A.
    Schiller, J. H.
    Ilagan, J.
    Harper, K.
    Vermeulen, W.
    Liu, G.
    Tye, L.
    Chao, R.
    Verkh, L.
    Traynor, A.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3514S - 3515S
  • [39] Phase I pharmacokinetic (PK) study of daily imatinib in combination with docetaxel for patients with advanced solid tumors.
    Chatta, GS
    Fakih, M
    Ramalingam, S
    Belani, CP
    Ramanathan, RK
    Zamboni, N
    Friedland, D
    Lis, D
    Tutchko, S
    Egorin, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 138S - 138S
  • [40] A phase I pharmacokinetic and pharmacodynamic study of intravenous calcitriol in combination with oral gefitinib in patients with advanced solid tumors
    Fakih, Marwan G.
    Trump, Donald L.
    Muindi, Josephia R.
    Black, Jennifer D.
    Bernardi, Ronald J.
    Creaven, Patrick J.
    Schwartz, James
    Brattain, Michael G.
    French, Renee
    Johnson, Candance S.
    CLINICAL CANCER RESEARCH, 2007, 13 (04) : 1216 - 1223